Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine

NCT06294262 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaccination Reaction

Interventions

BIOLOGICAL: TETRALITE

Sponsor

LiteVax BV

Collaborators

[object Object]
[object Object]